Clinical Trials Browser

Phase 2 × Lung Neoplasms × Bortezomib × Clear all

NCT00064012 2019-12-13

Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00068289 2013-06-24

Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Phase 2 Completed

Lung Neoplasms, Small Cell Lung Carcinoma